Status:
RECRUITING
Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China
Lead Sponsor:
Third Affiliated Hospital, Sun Yat-Sen University
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
3-75 years
Brief Summary
This real-world observational study aims to reveal the current status of the open-source artificial pancreas system (APS) use among people with T1DM in China and assess the glycemic efficacy and poten...
Detailed Description
This is a real-world observational study analyzing data on open-source artificial pancreas systems(APS) in people with T1DM in China. Data will collected during clinical routine, questionnaires, stand...
Eligibility Criteria
Inclusion
- diagnosed T1DM.
- Currently use open-source APS for at least 3 months.
- Willing and able to provide informed consent (or be a parent or other legally authorized representative) and to provide the data.
- reside in China.
Exclusion
- None
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06081231
Start Date
January 1 2019
End Date
June 1 2026
Last Update
June 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinhua Yan
Guangzhou, Guangdong, China, 510630